Product Information
HYDROCORTISONE 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3006 per EA under NDC 59651041501. Its NADAC has been published 145 times since Dec 27, 2023.
FDA first approved this application on Jul 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651041501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONEApproval Type
Generic (ANDA)
FDA Application
ANDA214649FDA Approved
7/17/2023
TE Code
AB
On Market Since
7/17/2023
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORTISONE 20 MG TABLET has been published 145 times since Dec 27, 2023, and over the history we have for it it has declined 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3006 per EA |
|---|---|
| All-time high | $0.5303 (Jan 10, 2024) |
| All-time low | $0.2769 (Apr 22, 2026) |
| 52-week high | $0.4148 |
| 52-week low | $0.2769 |
| Median price | $0.3478 |
| Average price | $0.3720 |
| Largest weekly change | +35.4% (Aug 21, 2024) |
| Weeks tracked | 145 |
| Tracking since | Dec 27, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROCORTISONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROCORTISONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORTISONE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORTISONE 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3006 per EA (NDC 59651041501), effective Sep 30, 2026.
How has the price of HYDROCORTISONE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCORTISONE 20 MG TABLET has declined 43.3%. It has been tracked across 145 weekly CMS publications since Dec 27, 2023.
What are the highest and lowest recorded NADAC prices for HYDROCORTISONE 20 MG TABLET?
Since Dec 27, 2023, the NADAC for HYDROCORTISONE 20 MG TABLET has ranged from a low of $0.2769 (Apr 22, 2026) to a high of $0.5303 (Jan 10, 2024), with a median of $0.3478 per EA.
Are there cheaper alternatives to HYDROCORTISONE 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCORTISONE 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCORTISONE 20 MG TABLET?
HYDROCORTISONE 20 MG TABLET (NDC 59651041501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.